NCT04278118View on ClinicalTrials.gov

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2031

Conditions
Grade I MeningiomaGrade II MeningiomaGrade III MeningiomaIntracranial NeoplasmNerve Sheath NeoplasmPituitary Gland AdenomaSchwannoma
Interventions
RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated proton or photon radiation therapy

RADIATION

Photon Beam Radiation Therapy

Undergo hypofractionated proton or photon radiation therapy

RADIATION

Proton Beam Radiation Therapy

Undergo hypofractionated proton or photon radiation therapy

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

30322

RECRUITING

Emory University Hospital/Winship Cancer Institute, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER